The following adverse medicinal product reactions have been identified or suspected for esomeprazole administered orally or intravenously. (See table.)
Click on icon to see table/diagram/image
Irreversible visual impairment has been reported in isolated cases of critically ill patients who have received omeprazole (the racemate) intravenous injection, especially at high doses, but no causal relationship has been established.